Top-News
Professionelle Dienstleistungen Schweiz

Relief Therapeutics Holding News

Aktie
WKN:  A3EFB5 ISIN:  CH1251125998 US-Symbol:  RLFTF
1,19 $
-0,06 $
-4,80%
19:29:13 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
14,04 Mio.
Marktkapitalisierung *
16,23 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 09.05.2023

Relief Therapeutics Holding News

03.05.23 - DGAP
Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares 03.05.2023 / 07:00 ...
01.05.23 - DGAP
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule
Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of ...
28.04.23 - DGAP
Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders 28.04.2023 / 19:00 CET/CEST
17.04.23 - DGAP
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
Relief Therapeutics Holding SA / Key word(s): Research Update Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-...
14.04.23 - DGAP
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update 14-Apr-2023 / 07:00 ...
05.04.23 - DGAP
Relief Therapeutics Announces Executive Leadership Team Change
Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Announces Executive Leadership Team Change 05-Apr-2023 / 07:00 CET/CEST Release of an ad hoc ...
04.04.23 - DGAP
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders 04-Apr-2023 / 07:00 CET/CEST ...
03.04.23 - DGAP
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Appoints World-​Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory ...
22.03.23 - DGAP
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented ...
17.03.23 - DGAP
Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics to Present Pre-​Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society ...
16.03.23 - DGAP
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe 16.03.2023 / 07:00 CET/CEST
15.03.23 - DGAP
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™ 
Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™  15-March-2023 / 07:00 CET/CEST ...
28.02.23 - DGAP
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars ...
14.02.23 - DGAP
Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa
Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces Enrollment of First Three Patients in Proof-​of-Concept Clinical Trial of RLF-TD011 for the ...
08.02.23 - DGAP
Relief Therapeutics Provides an Update on its Financing Strategy
Relief Therapeutics Holding SA / Key word(s): Financing Relief Therapeutics Provides an Update on its Financing Strategy 08-Feb-2023 / 07:00 CET/CEST Release of an ad hoc ...
17.01.23 - DGAP
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces IRB Approval of Investigator-​Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for ...
27.12.22 - DGAP
Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission
Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and ...
27.12.22 - DGAP
Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders
Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle ...
20.12.22 - DGAP
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements
Relief Therapeutics Holding SA / Key word(s): Legal Matter Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements 20-...
14.12.22 - DGAP
Relief Therapeutics to Participate in January Investor Meetings
Relief Therapeutics Holding SA / Key word(s): Conference Relief Therapeutics to Participate in January Investor Meetings 14.12.2022 / 07:00 CET/CEST

Newssuche

Videos

newspaper
10:20 Uhr +11,59%
Technical Trading: Zukauf-​Chance bei Top-Trade, wenn
Sugar No.11 Long Typ: Turbo Open End WKN: VV50DP Hebel: 5 Laufzeit: OpenEnd Einstieg: prozyklisch ... Mehr »